GlobalData on MSN
AtaCor raises $75m for trial of EV-ICD system
The US FDA study is intended to evaluate the system for treating life-threatening ventricular tachyarrhythmias.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback